BioFire’s syndromic approach increases the probability of identifying a pathogen in patients with symptoms of an infectious disease and increases capability of detection of co-infections. The FilmArray® System’s PCR technology for detection of bacteria, viruses, and parasites offers increased sensitivity of 98.5% and specificity of 99.3%, better than traditional methods, particularly for difficult to culture organisms. The addition of GDH/Toxin testing via EIA is intended to aid in the distinction between colonization and active C. difficile infection. This will assist in optimum patient management and the avoidance of inappropriate treatment of colonized patients. Rapid technology with results routinely available to clinicians within 24 hours.
Now includes ADD-ON Testing to expand diagnostic capabilities: H. pylori, Calprotectin, Pancreatic Elastase, Fecal Fat -